IRIS
AQUARO, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.500
EU - Europa 2.583
AS - Asia 868
AF - Africa 116
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 5
SA - Sud America 4
Totale 8.087
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.378
UA - Ucraina 1.239
DE - Germania 638
CN - Cina 343
SE - Svezia 264
SG - Singapore 219
TR - Turchia 181
IT - Italia 139
CA - Canada 121
SN - Senegal 109
AT - Austria 89
HK - Hong Kong 83
FR - Francia 70
FI - Finlandia 61
RU - Federazione Russa 21
IN - India 20
BE - Belgio 19
GB - Regno Unito 15
EU - Europa 10
RO - Romania 7
ES - Italia 5
CZ - Repubblica Ceca 4
AU - Australia 3
ET - Etiopia 3
KG - Kirghizistan 3
KR - Corea 3
AL - Albania 2
BO - Bolivia 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NL - Olanda 2
NZ - Nuova Zelanda 2
PL - Polonia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BR - Brasile 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
GH - Ghana 1
GR - Grecia 1
IQ - Iraq 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
PE - Perù 1
RE - Reunion 1
ZA - Sudafrica 1
Totale 8.087
Salva come PNG Salva come JPEG
Città #
Jacksonville 865
Chandler 614
Dearborn 447
Boardman 437
San Mateo 344
Lawrence 187
Roxbury 183
Izmir 179
New York 135
Shanghai 124
Des Moines 119
Ottawa 110
Dakar 109
Singapore 108
Cambridge 83
Beijing 70
Ann Arbor 66
Wilmington 65
Vienna 63
Ashburn 62
Helsinki 60
Grafing 51
Ogden 49
Brooklyn 44
Inglewood 30
Rende 26
Seattle 22
Brussels 19
Hong Kong 18
Los Angeles 17
Rome 14
Strasbourg 14
Norwalk 10
Wuhan 10
Guangzhou 9
Toronto 9
Munich 8
Nanjing 8
Bremen 7
Florence 7
San Francisco 7
Jiaxing 6
London 6
Milan 6
Pune 6
West Jordan 6
Shenyang 5
Brno 4
Chicago 4
Haikou 4
Jinan 4
Moscow 4
Princeton 4
St Petersburg 4
Amantea 3
Bishkek 3
Falkenstein 3
Gatchina 3
Hefei 3
Houston 3
Jinhua 3
Kunming 3
Melbourne 3
Nanchang 3
Newark 3
Palermo 3
Redmond 3
Seoul 3
Auckland 2
Avignon 2
Bitonto 2
Cedar Knolls 2
Cellatica 2
Changsha 2
Delhi 2
Dublin 2
Esslingen am Neckar 2
Falls Church 2
Hangzhou 2
Kazan' 2
La Paz 2
Madrid 2
Perm 2
Perugia 2
Riyadh 2
Secaucus 2
Shenzhen 2
Taranto 2
Vientiane 2
Washington 2
Woodbridge 2
Wuxi 2
Yiwu 2
Zhengzhou 2
Aarau 1
Accra 1
Amsterdam 1
Andover 1
Arbil 1
Athens 1
Totale 4.972
Salva come PNG Salva come JPEG
Nome #
1,2,3-triazole-TSAO analogues: Synthesis and anti-HIV activity 151
Identification of chlorocarbazole derivatives as potential antiviral agents. 102
Carbazole Derivatives as Antiviral Agents: An Overview 101
Progettazione, studio di docking molecolare e sintesi di nuove molecole capaci di interagire con il virus responsabile della SARS-COVID 19. 93
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 90
Apoptosis in Human Astrocytic Cells Induced by HIV-Infected Macrophages 83
Cachrys spp. from Southern Italy: Phytochemical Characterization and JAK/STAT Signaling Pathway Inhibition 82
ANTIBACTERIAL AND ANTIVIRAL PHARMACEUTICAL COMPOSITION 82
Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs. 78
Antiretrovirus activity of novel class of acyclic pyrimidine nucleoside phosphonates 78
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: new evidence and future perspectives 77
Anti-HIV efficacy in primary monocyte/macrphage by phosphorylated and phosphonated derivatives of nucleside analogues 70
Antiviral activity of amprenavir in human macrophages acutely and chronically infected by HIV-1 70
Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity 70
Activity of masked 2’-3’-dideoxynucleoside-monophosphate derivatives against human immunodeficiency virus in resting macrophages 70
Anti-nerve Growth Factor Antibody Abrogates Macrophages-mediated HIV-1 Infection and Depletion of CD4+ T-lymphocytes in hu-SCID Mice 68
AZT treatment of HIV-1 infected macrophages prevents apoptosis and necrosis in human astrocytic cells 67
Activity of GM-CSF and M-CSF upon Replication of HIV and Other DNA- and RNA-Viruses in Primary Macrophages 67
Anti-HIV activity of protease inhibitors in productively-infected macrophages and correlation with clinical outcome 67
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90. 67
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies. 65
Anti-HIV activity of nucleoside analogues in mononuclear cells. Workshop on Recent advances in modified nucleosides 64
Activity of masked 2’-3’-Dideoxynucleoside Monophosphate Derivatives Against Human Immunodeficiency Virus in Resting Macrophages 63
Analisi mediante PCR dell’influenza di citochine sulla replicazione virale di HIV-1 e HSV-1 in macrofagi primari umani 62
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 61
Anti-nerve growth factor Ab abrogates macrophage mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice 60
Acyclic nucleoside phosphonates: A new class of compounds with antiviral and immunomodulatory activity 60
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 60
Understanding HIV compartments and reservoirs. 58
Antiviral efficacy of inhibitors of HIV protease in chronically-infected macrophages 57
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine [(R)-PMPA] and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine [(R)-PMPDAP] against Human Immunodeficiency Virus in Different Human Cell Systems 57
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics 57
Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus 56
Cyclosaligenil-2’,3’-didehydro-2’,3’ – dideoxythymidine Monophosphate: efficient Intracellular Delivery of d4TMP 56
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives 56
Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically-infected macrophages 55
Antiviral activity of nucleoside analogues in macrophages 55
Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir 54
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 53
Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus 51
Thidiazuron: New Trends and Future Perspectives to Fight Xylella fastidiosa in Olive Trees 50
Influenza virus A (H5N1): a pandemic risk? 50
Attivita’ di farmaci inibitori del virus dell’immunodeficienza umana in macrofagi umani e correlazione con l’efficacia clinica 49
Therapeutic strategies towards HIV-1 infection in macrophages 49
Glutathione inhibits HIV replication by acting at late stages of virus lifecycle 48
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 47
Factors affecting the anti-HIV and anti-HSV activity of nucleoside analogues in macrophages 47
Cytokines in HIV infection 47
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029. 46
The Potent Inhibition of Human Immunodeficiency Virus and Herpes Simplex Virus Type 1 by 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA) in Primary Macrophages Is Determined by Drug Metabolism, Nucleotide Pools and Cytokines 46
Nerve growth factor in an autocrine factor essential for the survival of macrophages infected by human immunodeficiency virus 45
Studio di fattori che influenzano l’attivita’ anti-HIV ed anti-HSV di analoghi nucleosidici nei monociti-macrofagi 45
Microbiological Characteristics and Physico-chemical Parameters of Fermented Milk Product Ergo-A Traditional Yogurt Product of Ethiopia 45
Comparative efficacy of antiviral compounds in monocytes/macrophages and lymphocytes infected by HIV 45
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 44
Latent infection of human herpesvirus type-7 in macrophage 44
oxidative stress and HIV infection:target pathways for novel therapies? 44
Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype. 44
The contribution of peroxynitrite generation in HIV replication in human primary macrophages 44
Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages 44
Il macrofago e l’infezione da HIV. Ruolo delle cellule lungo sopravviventi nella patogenesi e nella terapia. 44
HIV-1-mediated apoptosis occurs in macrophages infected by X4, but not by R5 viruses 44
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 43
Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist 43
NEUROAIDS: VIROLOGICAL ASPECTS OF HIV INFECTION 43
Modulazione dell’infezione da virus influenzale in macrofagi trattati con citochine 43
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies 43
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus 43
S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation 43
Development of resistance to anti-HIV drugs in primary macrophages 43
Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage 42
Le basi razionali della terapia di associazione nel trattamento dell’AIDS 41
Farmaci inibitori della replicazione di HIV nei macrofagi: Attivita’ antivirale in vitro e correlazione con l’efficacia clinica 41
Le mutazioni osservate nei macrofagi primari umani dopo trattamento con farmaci inibitori della transcrittasi inversa non conferiscono resistenza 41
The counter-current centrifugal elutriation (cee) as essential tool for purification of monocytes and the assessment of the activity of cytokines upon virus replication 41
Highly Favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 (HIV-1) replication 41
Macrofagi infettati da HIV provocano in vitro morte cellulare per apoptosi in cellule astrocitarie 40
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 40
Intracellular GSH content and HIV replication in human macrophages 39
Macrophages: a crucial reservoir for human immunodeficiency virus in the body 39
Inhibition of HIV replication in primary macrophages by antiviral drugs: Modulation by cytokines and comparative efficacy in lymphocytes 38
Selective targeting of antiviral compounds to macrophages via red blood cells drug delivery 38
TAK-779 blocca il corecettore CCR5 ed inibisce fortemente la replicazione di ceppi monocitotropi di HIV, in vitro ed in vivo 38
In vitro activity of inhibitors of late stages of the replication of HIV in chronically-infected macrophages 37
Razionale della terapia dell’encefalopatia da HIV-1: inibizione della replicazione virale in macrofagi 37
Phosphorylated and phosphonated derivatives of nucleoside analogues are more active against HIV in monocyte/macrophages than in lymphocytes 37
Modulazione della replicazione virale in macrofagi trattati con Granulocyte-Macrophage Colony Stimulating Factor 37
Replication of HIV-1 and HSV-1 in macrophages: Comparative activity of acyclic nucleoside phosphonates in the presence or absence of cytokines enhancers of virus replication 37
Long lasting and efficient inhibition of HIV replication in macrophages is obtained by reverse transcriptase inhibitors and their phosphorylated- and phosphonated derivatives 37
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4(+) T lymphocytes 37
Viral Dynamic and mutations in the Pol Gene during primary HIV-1 infection 37
Red-blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: efficiency, metabolism, and activity against human immunodeficiency virus or herpes simplex virus 37
Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages 37
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors. 37
M40401, a sod mimetic compound with a potent anti-HIV activity in macrophages, prevents apoptosis in astrocytes 36
Dinamica virale nei reservoirs. Infezioni da HIV: approfondimenti sul tema 35
Attività anti-HIV di differenti classi di farmaci antivirali di interesse clinico: valutazione in vitro dell’efficacia in monociti/macrofagi primari e linfociti 35
GM-CSF and M-CSF modulate the replication of HIV and other viruses in primary macrophages by acting on different steps of virus lifecycle 35
M40401, un composto sod-mimetico con potente attività anti-HIV nei macrofagi, previene l’apoptosi negli astrociti 35
Phosphorylation of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) is greater in macrophages than in replicating lymphocytes and fibroblasts 35
Totale 5.285
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.684
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.352 0 0 0 182 109 459 105 193 25 19 184 76
2020/20211.358 213 4 176 184 3 186 12 194 28 187 6 165
2021/20221.562 18 166 4 112 141 61 12 408 34 9 203 394
2022/20231.549 225 110 52 183 158 135 2 225 238 47 112 62
2023/2024893 89 25 56 28 48 172 23 35 109 30 47 231
2024/2025661 142 461 52 6 0 0 0 0 0 0 0 0
Totale 8.152